These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. 4-Methoxytranylcypromine, a monoamine oxidase inhibitor: effects on biogenic amines in rat brain following chronic administration. Sherry-McKenna RL; Baker GB; Mousseau DD; Coutts RT; Dewhurst WG Biol Psychiatry; 1992 May; 31(9):881-8. PubMed ID: 1353376 [TBL] [Abstract][Full Text] [Related]
4. N-(2-cyanoethyl)tranylcypromine, a potential prodrug of tranylcypromine: its disposition and interaction with catecholamine neurotransmitters in brain. Nazarali AJ; Baker GB; Coutts RT; Wong TF Pharm Res; 1987 Feb; 4(1):16-20. PubMed ID: 3508523 [TBL] [Abstract][Full Text] [Related]
5. Effects of low-dose 4-fluorotranylcypromine on rat brain monoamine oxidase and neurotransmitter amines. Sherry RL; Baker GB; Coutts RT Biol Psychiatry; 1990 Sep; 28(6):539-43. PubMed ID: 1699613 [No Abstract] [Full Text] [Related]
6. Chronic effects of tranylcypromine and 4-fluorotranylcypromine on regional brain monoamine metabolism in rats: a comparison with clorgyline. Greenshaw AJ; Rao TS; Nazarali AJ; Baker GB; Coutts RT Biol Psychiatry; 1989 Apr; 25(8):1014-20. PubMed ID: 2470425 [TBL] [Abstract][Full Text] [Related]
7. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration. Green AR; Youdim MB Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627 [TBL] [Abstract][Full Text] [Related]
8. Neurochemical changes in rat brain amines after short- and long-term inhibition of monoamine oxidase by a low dose of tranylcypromine. Hampson DR; Baker GB; Coutts RT Biol Psychiatry; 1988 Feb; 23(3):227-36. PubMed ID: 3337860 [TBL] [Abstract][Full Text] [Related]
9. Brain levels of 5-hydroxytryptamine, tryptamine and 2-phenylethylamine in the rat after administration of N-cyanoethyltranylcypromine. Baker GB; Nazarali AJ; Coutts RT; Micetich RG; Hall TW Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):657-60. PubMed ID: 6531437 [TBL] [Abstract][Full Text] [Related]
10. A comparison of the pharmacological and biochemical properties of substrate-selective monoamine oxidase inhibitors. Christmas AJ; Coulson CJ; Maxwell DR; Riddell D Br J Pharmacol; 1972 Jul; 45(3):490-503. PubMed ID: 5072232 [TBL] [Abstract][Full Text] [Related]
11. Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A. Da Prada M; Kettler R; Keller HH; Burkard WP; Muggli-Maniglio D; Haefely WE J Pharmacol Exp Ther; 1989 Jan; 248(1):400-14. PubMed ID: 2783611 [TBL] [Abstract][Full Text] [Related]
12. Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium. Lenzen S; Nahrstedt H; Panten U Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov; 324(3):190-5. PubMed ID: 6419132 [TBL] [Abstract][Full Text] [Related]
13. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors. Alemany R; Olmos G; GarcĂa-Sevilla JA Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544 [TBL] [Abstract][Full Text] [Related]
14. Fluorinated phenylcyclopropylamines. Part 3: Inhibition of monoamine oxidase A and B. Yoshida S; Rosen TC; Meyer OG; Sloan MJ; Ye S; Haufe G; Kirk KL Bioorg Med Chem; 2004 May; 12(10):2645-52. PubMed ID: 15110846 [TBL] [Abstract][Full Text] [Related]
15. N,N-dipropargyl-2-phenylethylamine, a potential prodrug of 2-phenylethylamine: neurochemical and neuropharmacological studies in rat. Rao TS; Baker GB; Coutts RT Brain Res Bull; 1987 Jul; 19(1):47-55. PubMed ID: 3651840 [TBL] [Abstract][Full Text] [Related]
16. The neuropharmacological profile of N-methyl-N-propargyl-2-aminotetralin: a potent monoamine oxidase inhibitor. Hazelhoff B; De Vries JB; Dijkstra D; de Jong W; Horn AS Naunyn Schmiedebergs Arch Pharmacol; 1985 Jul; 330(1):50-8. PubMed ID: 2413370 [TBL] [Abstract][Full Text] [Related]
17. Neurochemical and neuroprotective effects of some aliphatic propargylamines: new selective nonamphetamine-like monoamine oxidase B inhibitors. Yu PH; Davis BA; Durden DA; Barber A; Terleckyj I; Nicklas WG; Boulton AA J Neurochem; 1994 Feb; 62(2):697-704. PubMed ID: 8294932 [TBL] [Abstract][Full Text] [Related]
18. Monoamine oxidase inhibitors: effects on tryptophan concentrations in rat brain. Sherry-McKenna RL; Wong JT; Paetsch PR; Baker GB; Mousseau DD; McKenna KF; Coutts RT; Greenshaw AJ J Neural Transm Suppl; 1994; 41():155-63. PubMed ID: 7931222 [TBL] [Abstract][Full Text] [Related]
19. Detection and quantitation of a ring-hydroxylated metabolite of the antidepressant drug tranylcypromine. Baker GB; Hampson DR; Coutts RT; Micetich RG; Hall TW; Rao TS J Neural Transm; 1986; 65(3-4):233-43. PubMed ID: 3711885 [TBL] [Abstract][Full Text] [Related]
20. Tranylcypromine in mind (Part I): Review of pharmacology. Ulrich S; Ricken R; Adli M Eur Neuropsychopharmacol; 2017 Aug; 27(8):697-713. PubMed ID: 28655495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]